Abstract
Estrogen receptor alpha (ERα) has been demonstrated to play a key role in reproduction but also to exert numerous functions in nonreproductive tissues. Accordingly, ERα is now recognized as a key regulator of energy homeostasis and glucose metabolism and mediates the protective effects of estrogens against obesity and type 2 diabetes. This chapter attempts to summarize our current understanding of the mechanisms of ERα activation and their involvement in the modulation of energy balance and glucose metabolism. We first focus on the experimental studies that constitute the basis of the understanding of ERα as a nuclear receptor and more specifically on the key roles played by its two activation functions (AFs). We depict the consequences of the selective inactivation of these AFs in mouse models, which further underline the prominent role of nuclear ERα in the prevention of obesity and diabetes, as on the reproductive tract and the vascular system. Besides these nuclear actions, a fraction of ERα is associated with the plasma membrane and activates nonnuclear signaling from this site. Such rapid effects, called membrane-initiated steroid signals (MISS), have been characterized in a variety of cell lines and in particular in endothelial cells. The development of selective pharmacological tools that specifically activate MISS as well as the generation of mice expressing an ERα protein impeded for membrane localization has just begun to unravel the physiological role of MISS in vivo and their contribution to ERα-mediated metabolic protection. Finally, we discuss novel perspectives for the design of tissue-selective ER modulators.
References
Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, p., & Marino, M. (2005). Palmitoylation-dependent estrogen receptor alpha membrane localization: Regulation by 17beta-estradiol. Molecular Biology of the Cell, 16, 231–237.
Adlanmerini, M., Solinhac, R., Abot, A., Fabre, A., Raymond-Letron, I., Guihot, A. L., Boudou, F., Sautier, L., Vessieres, E., Kim, S. H., Liere, P., Fontaine, C., Krust, A., Chambon, P., Katzenellenbogen, J. A., Gourdy, P., Shaul, P. W., Henrion, D., Arnal, J. F., & Lenfant, F. (2014). Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proceedings of the National Academy of Sciences of the United States of America, 111, E283–E290.
Ahlbory-Dieker, D. L., Stride, B. D., Leder, G., Schkoldow, J., Trolenberg, S., Seidel, H., Otto, C., Sommer, A., Parker, M. G., Schutz, G., & Wintermantel, T. M. (2009). DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus. Molecular Endocrinology, 23, 1544–1555.
Ali, S., Metzger, D., Bornert, J. M., & Chambon, P. (1993). Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. The EMBO Journal, 12, 1153–1160.
Arao, Y., Hamilton, K. J., Ray, M. K., Scott, G., Mishina, Y., & Korach, K. S. (2011). Estrogen receptor alpha AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators. Proceedings of the National Academy of Sciences of the United States of America, 108, 14986–14991.
Arnal, J. F., Fontaine, C., Billon-gales, A., Favre, J., Laurell, H., Lenfant, F., & Gourdy, P. (2010). Estrogen receptors and endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 1506–1512.
Arnal, J. F., Lenfant, F., Metivier, R., Flouriot, G., Henrion, D., Adlanmerini, M., Fontaine, C., Gourdy, P., Chambon, P., Katzenellenbogen, B., & Katzenellenbogen, J. (2017). Membrane and nuclear estrogen receptor alpha actions: From tissue specificity to medical implications. Physiological Reviews, 97, 1045–1087.
Ascenzi, P., Bocedi, A., & Marino, M. (2006). Structure-function relationship of estrogen receptor alpha and beta: Impact on human health. Molecular Aspects of Medicine, 27, 299–402.
Billon-Gales, A., Fontaine, C., Douin-Echinard, V., Delpy, L., Berges, H., Calippe, B., Lenfant, F., Laurell, H., Guery, J. C., Gourdy, P., & Arnal, J. F. (2009a). Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation, 120, 2567–2576.
Billon-gales, A., Fontaine, C., Filipe, C., Douin-Echinard, V., Fouque, M. J., Flouriot, G., Gourdy, P., Lenfant, F., Laurell, H., Krust, A., Chambon, P., & Arnal, J. F. (2009b). The transactivating function 1 of estrogen receptor {alpha} is dispensable for the vasculoprotective actions of 17{beta}-estradiol. Proceedings of the National Academy of Sciences of the United States of America, 106, 2053–2058.
Billon-Gales, A., Krust, A., Fontaine, C., Abot, A., Flouriot, G., Toutain, C., Berges, H., Gadeau, A. P., Lenfant, F., Gourdy, P., Chambon, P., & Arnal, J. F. (2011). Activation function 2 (AF2) of estrogen receptor-{alpha} is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proceedings of the National Academy of Sciences of the United States of America, 108, 13311–13316.
Bolego, C., Cignarella, A., Sanvito, P., Pelosi, V., Pellegatta, F., Puglisi, L., & Pinna, C. (2005). The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation. The Journal of Pharmacology and Experimental Therapeutics, 313, 1203–1208.
Bonds, D. E., Lasser, N., Qi, L., Brzyski, R., Caan, B., Heiss, G., Limacher, M. C., Liu, J. H., Mason, E., Oberman, A., O’sullivan, M. J., Phillips, L. S., Prineas, R. J., & Tinker, L. (2006). The effect of conjugated equine oestrogen on diabetes incidence: The women’s health initiative randomised trial. Diabetologia, 49, 459–468.
Borjesson, A. E., Windahl, S. H., Lagerquist, M. K., Engdahl, C., Frenkel, B., Moverare-Skrtic, S., Sjogren, K., Kindblom, J. M., Stubelius, A., Islander, U., Antal, M. C., Krust, A., Chambon, P., & Ohlsson, C. (2011). Roles of transactivating functions 1 and 2 of estrogen receptor-{alpha} in bone. Proceedings of the National Academy of Sciences of the United States of America, 108, 6288–6293.
Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F., & Arnal, J. F. (2001). Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation, 103, 423–428.
Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A., & Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389, 753–758.
Bunone, G., Briand, P. A., Miksicek, R. J., & Picard, D. (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. The EMBO Journal, 15, 2174–2183.
Carson-Jurica, M. A., Schrader, W. T., & O’malley, B. W. (1990). Steroid receptor family: Structure and functions. Endocrine Reviews, 11, 201–220.
Caulin-Glaser, T., Garcia-Cardena, G., Sarrel, P., Sessa, W. C., & Bender, J. R. (1997). 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circulation Research, 81, 885–892.
Chambliss, K. L., Yuhanna, I. S., Anderson, R. G., Mendelsohn, M. E., & Shaul, P. W. (2002). ERbeta has nongenomic action in caveolae. Molecular Endocrinology, 16, 938–946.
Chambliss, K. L., Wu, Q., Oltmann, S., Konaniah, E. S., Umetani, M., Korach, K. S., Thomas, G. D., Mineo, C., Yuhanna, I. S., Kim, S. H., Madak-Erdogan, Z., Maggi, A., Dineen, S. P., Roland, C. L., Hui, D. Y., Brekken, R. A., Katzenellenbogen, J. A., Katzenellenbogen, B. S., & Shaul, P. W. (2010). Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. The Journal of Clinical Investigation, 120, 2319–2330.
Chambliss, K. L., Barrera, J., Umetani, M., Umetani, J., Kim, S. H., Madak-Erdogan, Z., Huang, L., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Mineo, C., & Shaul, P. W. (2016). Nonnuclear estrogen receptor activation improves hepatic steatosis in female mice. Endocrinology, 157, 3731–3741.
Chantalat, E., Boudou, F., Laurell, H., Palierne, G., Houtman, R., Melchers, D., Rochaix, P., Filleron, T., Stella, A., Burlet-Schiltz, O., Brouchet, A., Flouriot, G., Metivier, R., Arnal, J. F., Fontaine, C., & Lenfant, F. (2016). The AF-1-deficient estrogen receptor ERalpha46 isoform is frequently expressed in human breast tumors. Breast Cancer Research, 18, 123.
Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999). Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. The Journal of Clinical Investigation, 103, 401–406.
Chen, D. B., Bird, I. M., Zheng, J., & Magness, R. R. (2004). Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology, 145, 113–125.
Cooke, P. S., Heine, P. A., Taylor, J. A., & Lubahn, D. B. (2001). The role of estrogen and estrogen receptor-alpha in male adipose tissue. Molecular and Cellular Endocrinology, 178, 147–154.
Dan, P., Cheung, J. C., Scriven, D. R., & Moore, E. D. (2003). Epitope-dependent localization of estrogen receptor-alpha, but not -beta, in en face arterial endothelium. American Journal of Physiology. Heart and Circulatory Physiology, 284, H1295–H1306.
Danielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. The EMBO Journal, 11, 1025–1033.
Darblade, B., Pendaries, C., Krust, A., Dupont, S., Fouque, M. J., Rami, J., Chambon, P., Bayard, F., & Arnal, J. F. (2002). Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circulation Research, 90, 413–419.
Davis, K. E., Carstens, E. J., Irani, B. G., Gent, L. M., Hahner, L. M., & Clegg, D. J. (2014). Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Hormones and Behavior, 66, 196–207.
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000). Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development, 127, 4277–4291.
Filardo, E. J., Quinn, J. A., Bland, K. I., & Frackelton, A. R., Jr. (2000). Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Molecular Endocrinology, 14, 1649–1660.
Foulds, C. E., Feng, Q., Ding, C., Bailey, S., Hunsaker, T. L., Malovannaya, A., Hamilton, R. A., Gates, L. A., Zhang, Z., Li, C., Chan, D., Bajaj, A., Callaway, C. G., Edwards, D. P., Lonard, D. M., Tsai, S. Y., Tsai, M. J., Qin, J., & O’Malley, B. W. (2013). Proteomic analysis of coregulators bound to ERalpha on DNA and nucleosomes reveals coregulator dynamics. Molecular Cell, 51, 185–199.
Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J. E., & Sessa, W. C. (1996). Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proceedings of the National Academy of Sciences of the United States of America, 93, 6448–6453.
Green, S., & Chambon, P. (1987). Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature, 325, 75–78.
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., & Chambon, P. (1986). Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature, 320, 134–139.
Grumbach, M. M., & Auchus, R. J. (1999). Estrogen: Consequences and implications of human mutations in synthesis and action. The Journal of Clinical Endocrinology and Metabolism, 84, 4677–4694.
Guillaume, M., Handgraaf, S., Fabre, A., Raymond-Letron, I., Riant, E., Montagner, A., Vinel, A., Buscato, M., Smirnova, N., Fontaine, C., Guillou, H., Arnal, J. F., & Gourdy, P. (2017). Selective activation of estrogen receptor alpha activation function-1 is sufficient to prevent obesity, steatosis, and insulin resistance in mouse. The American Journal of Pathology, 187, 1273–1287.
Hafezi-Moghadam, A., Simoncini, T., Yang, Z., Limbourg, F. P., Plumier, J. C., Rebsamen, M. C., Hsieh, C. M., Chui, D. S., Thomas, K. L., Prorock, A. J., Laubach, V. E., Moskowitz, M. A., French, B. A., Ley, K., & Liao, J. K. (2002). Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nature Medicine, 8, 473–479.
Hammes, S. R., & Levin, E. R. (2007). Extranuclear steroid receptors: Nature and actions. Endocrine Reviews, 28, 726–741.
Handgraaf, S., Riant, E., Fabre, A., Waget, A., Burcelin, R., Liere, P., Krust, A., Chambon, P., Arnal, J. F., & Gourdy, P. (2013). Prevention of obesity and insulin resistance by estrogens requires ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable. Diabetes, 62, 4098–4108.
Harrington, W. R., Kim, S. H., Funk, C. C., Madak-Erdogan, Z., Schiff, R., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2006). Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Molecular Endocrinology, 20, 491–502.
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000). Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 12729–12734.
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., & Gustafsson, J. A. (2007). Estrogen receptors: How do they signal and what are their targets. Physiological Reviews, 87, 905–931.
Hewitt, S. C., Li, L., Grimm, S. A., Winuthayanon, W., Hamilton, K. J., Pockette, B., Rubel, C. A., Pedersen, L. C., Fargo, D., Lanz, R. B., Demayo, F. J., Schutz, G., & Korach, K. S. (2014). Novel DNA motif binding activity observed in vivo with an estrogen receptor alpha mutant mouse. Molecular Endocrinology, 28, 899–911.
Horwitz, K. B., Jackson, T. A., Bain, D. L., Richer, J. K., Takimoto, G. S., & Tung, L. (1996). Nuclear receptor coactivators and corepressors. Molecular Endocrinology, 10, 1167–1177.
Iafrati, M. D., Karas, R. H., Ronovitz, M., Kim, S., Sullivan, T. R., Jr., Lubahn, D. B., O’donnell, T. F., Jr., Korach, K. S., & Mendelsohn, M. E. (1997). Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nature Medicine, 3, 545–548.
Jakacka, M., Ito, M., Martinson, F., Ishikawa, T., Lee, E. J., & Jameson, J. L. (2002). An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Molecular Endocrinology, 16, 2188–2201.
Jensen, E. V., & Desombre, E. R. (1973). Estrogen-receptor interaction. Science, 182, 126–134.
Jones, M. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., PROIETTO, J., Oz, O. K., Leury, B. J., Robertson, K. M., Yao, S., & Simpson, E. R. (2000). Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proceedings of the National Academy of Sciences of the United States of America, 97, 12735–12740.
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003). Glycemic effects of postmenopausal hormone therapy: The heart and estrogen/progestin replacement study. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 138, 1–9.
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., & Chambon, P. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science, 270, 1491–1494.
Krust, A., Green, S., Argos, P., Kumar, V., Walter, P., Bornert, J. M., & Chambon, P. (1986). The chicken oestrogen receptor sequence: Homology with v-erbA and the human oestrogen and glucocorticoid receptors. The EMBO Journal, 5, 891–897.
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R., Jr. (2005). Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Research, 65, 5317–5324.
Kumar, R., & Thompson, E. B. (1999). The structure of the nuclear hormone receptors. Steroids, 64, 310–319.
Kumar, P., Wu, Q., Chambliss, K. L., Yuhanna, I. S., Mumby, S. M., Mineo, C., Tall, G. G., & Shaul, P. W. (2007). Direct interactions with G alpha i and G betagamma mediate nongenomic signaling by estrogen receptor alpha. Molecular Endocrinology, 21, 1370–1380.
Lange, C. A., Gioeli, D., Hammes, S. R., & Marker, P. C. (2007). Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annual Review of Physiology, 69, 171–199.
Langer, G., Bader, B., Meoli, L., Isensee, J., Delbeck, M., Noppinger, P. R., & Otto, C. (2010). A critical review of fundamental controversies in the field of GPR30 research. Steroids, 75, 603–610.
Lantin-Hermoso, R. L., Rosenfeld, C. R., Yuhanna, I. S., German, Z., Chen, Z., & Shaul, P. W. (1997). Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. The American Journal of Physiology, 273, L119–L126.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T. M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., Hilsenbeck, S. G., Osborne, C. K., Glass, C. K., Rosenfeld, M. G., & Rose, D. W. (1998). Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proceedings of the National Academy of Sciences of the United States of America, 95, 2920–2925.
Le May, C., Chu, K., Hu, M., Ortega, C. S., Simpson, E. R., Korach, K. S., Tsai, M. J., & Mauvais-Jarvis, F. (2006). Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proceedings of the National Academy of Sciences of the United States of America, 103, 9232–9237.
Le Romancer, M., Treilleux, I., Leconte, N., Robin-Lespinasse, Y., Sentis, S., Bouchekioua-Bouzaghou, K., Goddard, S., Gobert-Gosse, S., & Corbo, L. (2008). Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Molecular Cell, 31, 212–221.
Le Romancer, M., Poulard, C., Cohen, P., Sentis, S., Renoir, J. M., & Corbo, L. (2011). Cracking the estrogen receptor’s posttranslational code in breast tumors. Endocrine Reviews, 32, 597–622.
Lees, J. A., Fawell, S. E., & Parker, M. G. (1989). Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor. Journal of Steroid Biochemistry, 34, 33–39.
Leong, H., Sloan, J. R., Nash, P. D., & Greene, G. L. (2005). Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha. Molecular Endocrinology, 19, 2930–2942.
Levin, E. R. (2009). G protein-coupled receptor 30: Estrogen receptor or collaborator? Endocrinology, 150, 1563–1565.
Levin, E. R., & Hammes, S. R. (2016). Nuclear receptors outside the nucleus: Extranuclear signalling by steroid receptors. Nature Reviews. Molecular Cell Biology, 17, 783–797.
Levin, E. R., & Pietras, R. J. (2008). Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Research and Treatment, 108, 351–361.
Li, L., Haynes, M. P., & Bender, J. R. (2003). Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 4807–4812.
Liu, S., & Mauvais-Jarvis, F. (2010). Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology, 151, 859–864.
Liu, Z., Merkurjev, D., Yang, F., Li, W., Oh, S., Friedman, M. J., Song, X., Zhang, F., Ma, Q., Ohgi, K. A., Krones, A., & Rosenfeld, M. G. (2014). Enhancer activation requires trans-recruitment of a mega transcription factor complex. Cell, 159, 358–373.
Lonard, D. M., & O’malley, B. W. (2007). Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Molecular Cell, 27, 691–700.
Louet, J. F., Lemay, C., & Mauvais-Jarvis, F. (2004). Antidiabetic actions of estrogen: Insight from human and genetic mouse models. Current Atherosclerosis Reports, 6, 180–185.
Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., & Smithies, O. (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proceedings of the National Academy of Sciences of the United States of America, 90, 11162–11166.
Madak-Erdogan, Z., Kim, S. H., Gong, P., Zhao, Y. C., Zhang, H., Chambliss, K. L., Carlson, K. E., Mayne, C. G., Shaul, P. W., Korach, K. S., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2016). Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues. Science Signaling, 9, ra53.
Mader, S., Kumar, V., De Verneuil, H., & Chambon, P. (1989). Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature, 338, 271–274.
Mangelsdorf, D. J., & Evans, R. M. (1995). The RXR heterodimers and orphan receptors. Cell, 83, 841–850.
Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., & Howard, B. V. (2004). Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: Results from the Women's Health Initiative Hormone Trial. Diabetologia, 47, 1175–1187.
Marino, M., & Ascenzi, P. (2008). Membrane association of estrogen receptor alpha and beta influences 17beta-estradiol-mediated cancer cell proliferation. Steroids, 73, 853–858.
Mauvais-Jarvis, F. (2016). Role of sex steroids in beta cell function, growth, and survival. Trends in Endocrinology and Metabolism, 27, 844–855.
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017). Menopausal hormone therapy and type 2 diabetes prevention: Evidence, mechanisms, and clinical implications. Endocrine Reviews, 38, 173–188.
Mcdevitt, M. A., Glidewell-Kenney, C., Jimenez, M. A., Ahearn, P. C., Weiss, J., Jameson, J. L., & Levine, J. E. (2008). New insights into the classical and non-classical actions of estrogen: Evidence from estrogen receptor knock-out and knock-in mice. Molecular and Cellular Endocrinology, 290, 24–30.
Mckenna, N. J., & O’malley, B. W. (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 108, 465–474.
Mendelsohn, M. E., & Karas, R. H. (2010). Rapid progress for non-nuclear estrogen receptor signaling. The Journal of Clinical Investigation, 120, 2277–2279.
Metivier, R., Stark, A., Flouriot, G., Hubner, M. R., Brand, H., Penot, G., Manu, D., Denger, S., Reid, G., Kos, M., Russell, R. B., Kah, O., Pakdel, F., & Gannon, F. (2002). A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. Molecular Cell, 10, 1019–1032.
Metivier, R., Penot, G., Carmouche, R. P., Hubner, M. R., Reid, G., Denger, S., Manu, D., Brand, H., Kos, M., Benes, V., & Gannon, F. (2004). Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. The EMBO Journal, 23, 3653–3666.
Metzger, D., Ali, S., Bornert, J. M., & Chambon, P. (1995). Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. The Journal of Biological Chemistry, 270, 9535–9542.
Meyer, M. R., Prossnitz, E. R., & Barton, M. (2011). The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascular Pharmacology, 55, 17–25.
Moras, D., & Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: Structure and function. Current Opinion in Cell Biology, 10, 384–391.
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995). Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. The Journal of Clinical Endocrinology and Metabolism, 80, 3689–3698.
Mosselman, S., Polman, J., & Dijkema, R. (1996). ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Letters, 392, 49–53.
Nadal, A., Alonso-Magdalena, P., Soriano, S., Quesada, I., & Ropero, A. B. (2009). The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Molecular and Cellular Endocrinology, 304, 63–68.
O’brien, J. E., Peterson, T. J., Tong, M. H., Lee, E. J., Pfaff, L. E., Hewitt, S. C., Korach, K. S., Weiss, J., & Jameson, J. L. (2006). Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. The Journal of Biological Chemistry, 281, 26683–26692.
Palierne, G., Fabre, A., Solinhac, R., Le Peron, C., Avner, S., Lenfant, F., Fontaine, C., Salbert, G., Flouriot, G., Arnal, J. F., & Metivier, R. (2016). Changes in gene expression and estrogen receptor cistrome in mouse liver upon acute E2 treatment. Molecular Endocrinology, 30, 709–732.
Pare, G., Krust, A., Karas, R. H., Dupont, S., Aronovitz, M., Chambon, P., & Mendelsohn, M. E. (2002). Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circulation Research, 90, 1087–1092.
Park, C. J., Zhao, Z., Glidewell-Kenney, C., Lazic, M., Chambon, P., Krust, A., Weiss, J., Clegg, D. J., Dunaif, A., Jameson, J. L., & Levine, J. E. (2011). Genetic rescue of nonclassical ERalpha signaling normalizes energy balance in obese Eralpha-null mutant mice. The Journal of Clinical Investigation, 121, 604–612.
Pedram, A., Razandi, M., Sainson, R. C., Kim, J. K., Hughes, C. C., & Levin, E. R. (2007). A conserved mechanism for steroid receptor translocation to the plasma membrane. The Journal of Biological Chemistry, 282, 22278–22288.
Pedram, A., Razandi, M., Kim, J. K., O’mahony, F., Lee, E. Y., Luderer, U., & Levin, E. R. (2009). Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse. The Journal of Biological Chemistry, 284, 3488–3495.
Pedram, A., Razandi, M., O’mahony, F., Harvey, H., Harvey, B. J., & Levin, E. R. (2013). Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling. Science Signaling, 6, ra36.
Pedram, A., Razandi, M., Lewis, M., Hammes, S., & Levin, E. R. (2014). Membrane-localized estrogen receptor alpha is required for normal organ development and function. Developmental Cell, 29, 482–490.
Pedram, A., Razandi, M., Blumberg, B., & Levin, E. R. (2016). Membrane and nuclear estrogen receptor alpha collaborate to suppress adipogenesis but not triglyceride content. The FASEB Journal, 30, 230–240.
Pendaries, C., Darblade, B., Rochaix, P., Krust, A., Chambon, P., Korach, K. S., Bayard, F., & Arnal, J. F. (2002). The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proceedings of the National Academy of Sciences of the United States of America, 99, 2205–2210.
Razandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999). Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Molecular Endocrinology, 13, 307–319.
Reis, S. E., Gloth, S. T., Blumenthal, R. S., Resar, J. R., Zacur, H. A., Gerstenblith, G., & Brinker, J. A. (1994). Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation, 89, 52–60.
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science, 307, 1625–1630.
Riant, E., Waget, A., Cogo, H., Arnal, J. F., Burcelin, R., & Gourdy, P. (2009). Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology, 150, 2109–2117.
Russell, K. S., Haynes, M. P., Sinha, D., Clerisme, E., & Bender, J. R. (2000). Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proceedings of the National Academy of Sciences of the United States of America, 97, 5930–5935.
Schwabe, J. W., Neuhaus, D., & Rhodes, D. (1990). Solution structure of the DNA-binding domain of the oestrogen receptor. Nature, 348, 458–461.
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000). Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature, 407, 538–541.
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. The New England Journal of Medicine, 331, 1056–1061.
Stefano, G. B., Prevot, V., Beauvillain, J. C., Cadet, P., Fimiani, C., Welters, I., Fricchione, G. L., Breton, C., Lassalle, P., Salzet, M., & Bilfinger, T. V. (2000). Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation, 101, 1594–1597.
Thomas, C., & Gustafsson, J. A. (2011). The different roles of ER subtypes in cancer biology and therapy. Nature Reviews Cancer, 11, 597–608.
Tiano, J. P., & Mauvais-Jarvis, F. (2012a). Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nature Reviews. Endocrinology, 8, 342–351.
Tiano, J. P., & Mauvais-Jarvis, F. (2012b). Molecular mechanisms of estrogen receptors’ suppression of lipogenesis in pancreatic beta-cells. Endocrinology, 153, 2997–3005.
Tiano, J. P., Delghingaro-Augusto, V., Le May, C., Liu, S., Kaw, M. K., Khuder, S. S., Latour, M. G., Bhatt, S. A., Korach, K. S., Najjar, S. M., Prentki, M., & Mauvais-Jarvis, F. (2011). Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes. The Journal of Clinical Investigation, 121, 3331–3342.
Vinel, A., Hay, E., Valera, M. C., Buscato, M., Adlanmerini, M., Guillaume, M., Cohen-Solal, M., Ohlsson, C., Lenfant, F., Arnal, J. F., & Fontaine, C. (2016). Role of ERalpha in the effect of estradiol on cancellous and cortical femoral bone in growing female mice. Endocrinology, 157, 2533–2544.
Wedisinghe, L., & Perera, M. (2009). Diabetes and the menopause. Maturitas, 63, 200–203.
Wu, Q., Chambliss, K., Umetani, M., Mineo, C., & Shaul, P. W. (2011). Non-nuclear estrogen receptor signaling in the endothelium. The Journal of Biological Chemistry, 286, 14737–14743.
Ylikomi, T., Bocquel, M. T., Berry, M., Gronemeyer, H., & Chambon, P. (1992). Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. The EMBO Journal, 11, 3681–3694.
Zhou, J., Li, Y. S., & Chien, S. (2014). Shear stress-initiated signaling and its regulation of endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 2191–2198.
Acknowledgments
The authors thank Raphael Metivier and Gilles Flouriot (Rennes, France), Pierre Chambon (Strasbourg, France), and John and Benita Katzenellenbogen (Urbana, USA) for long-term collaboration and fruitful discussions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Guillaume, M., Montagner, A., Fontaine, C., Lenfant, F., Arnal, JF., Gourdy, P. (2017). Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis. In: Mauvais-Jarvis, F. (eds) Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Advances in Experimental Medicine and Biology, vol 1043. Springer, Cham. https://doi.org/10.1007/978-3-319-70178-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-70178-3_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70177-6
Online ISBN: 978-3-319-70178-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)